Tsuchida, Takuma
Friedman, Scott L.
Article History
First Online: 10 May 2017
Competing interests
: S.L.F. is a consultant to 3-V Biotherapeutics, Abbvie Pharmaceuticals, Angion Biomedica, Akarna Therapeutics, Blade Therapeutics, Blueprint medicines, Boehringer Ingelheim, Bristol Myers Squibb, Can-Fite Biopharma, Chemocentryx, Conatus, Daichi Sankyo, Debio Pharmaceuticals, Deerfield consulting, DeuteRx, DS Biosciences, Eli Lilly Pharmaceuticals, Enanta Pharmaceuticals, Exalenz Biosciences, Fibrogen, Fractyl Bioscience, Galectin Therapeutics, Galmed, Genfit, Genkyotex, Glycotest, Glympse Bio, GNI Group, Immune Pharmaceuticals, Intercept, Ironwood Pharmaceuticals, Isis Pharmaceuticals, Janssen Pharmaceuticals, Jecure Therapeutics, Madrigal Pharmaceuticals, Metacrine, Metagenix, Merck Pharmaceuticals, Nimbus Therapeutics, Nitto, Northern Biologics, Novartis, Ocera Therapeutics, Pfizer, Raptor Pharmaceuticals, Roche, RuiYi, Sandhill Medical Devices, Scholar Rock, Shire Pharmaceuticals, Synageva BioPharma, Takeda Pharmaceuticals, Teva Pharmaceuticals, Tobira Therapeutics, Tokai Pharmaceuticals, Viking Therapeutics and Zafgen. T.T. is an employee of Mitsubushi Tanabe Pharma, Japan.